Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cortical Encephalitis in GFAP-IgG Astrocytopathy: A Case Report
Autoimmune Neurology
P5 - Poster Session 5 (5:30 PM-6:30 PM)
14-018
NA

A 23-year-old male presented with acute headache, fever and neck pain associated with urinary retention. Initial exam showed nuchal rigidity, and a full neuroaxis MRI was unremarkable. He was empirically treated for meningitis. CSF revealed lymphocytic pleocytosis with negative extensive microbial studies. Course was complicated by paraplegia and acute encephalopathy requiring intubation. Repeat MRI showed diffuse cortical encephalitis, brainstem leptomeningeal enhancement, dotted cerebellar and ganglionic perivascular enhancement, and a non-enhancing cervical longitudinally extensive myelitis. Repeat CSF was positive for unmatched oliogoclonal bands and GFAP-IgG by cell-based assay. Body PET was negative for neoplasms. He was treated with pulse corticosteroids, plasmapheresis, and rituximab with subsequent mental status improvement and extubation. Subsequent MRI showed cortical improvement but persistence of the brainstem changes. Upon long-term follow-up, he was walking independently and had returned back to his normal baseline. 

NA

NA

GFAP-IgG astrocytopathy is classically characterized by meningnoencephalomyelitis with radial perivascular enhancement. Diffuse cortical encephalitis seen in this case expands the radiological phenotype of this rare disease.
Authors/Disclosures
Mohammed Albedaiwi, MBBS
PRESENTER
Dr. Albedaiwi has nothing to disclose.
David Wang, MD (UnityPoint Health) Dr. Wang has nothing to disclose.
Hesham A. Abboud, MD (University Hospitals Cleveland Medical Center) Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.